(Q43546756)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-I(Zaragoza) (L144R) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Delia Recalde

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

W Velez-Carrasco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

F Civeira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Cenarro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D Gomez-Coronado

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Pocovi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

613-623

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Familial lipoprotein disorders in patients with premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Familial hypo-alpha-lipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Apolipoprotein A-IGiessen (Pro143----Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Variant apolipoprotein AI as a major constituent of a human hereditary amyloid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Isolation and characterization of human apolipoprotein A-I Fukuoka (110 Glu----Lys). A novel apolipoprotein variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Apolipoprotein A-I(Zavalla) (Leu159-->Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

A cysteine-containing truncated apo A-I variant associated with HDL deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Apolipoprotein A-IFin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Bimodal distribution of cholesteryl ester transfer protein activities in normotriglyceridemic men with low HDL cholesterol concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Apolipoprotein A-I containing lipoproteins in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Unique epitope of apolipoprotein A-I expressed in pre-beta-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Metabolism of High-Density Lipoprotein Apolipoproteins in Tangier Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Familial HDL deficiency due to marked hypercatabolism of normal apoA-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Very low high-density lipoproteins without coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900555-4

10.1016/S0021-9150(00)00555-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11257262%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference